ENTITY
Shinpoong Pharmaceutical

Shinpoong Pharmaceutical (019170 KS)

72
Analysis
Health CareSouth Korea
Shin Poong Pharmaceutical Co., Ltd. manufactures pharmaceutical raw materials and prescription drugs, such as cephalosporin antibiotics, hemostatics, sedative agents, and anti-diabetics.
more
Refresh
bullishHotel Shilla
09 Feb 2022 15:24

KOSPI Size Index Series Rebalancing Screening Results

This post has the screening results of the KOSPI Size Index Series rebalancing: 14 new MidCap entrants are expected to have a sizable passive impact.

Logo
275 Views
Share
07 Jan 2022 00:54

Shinpoong Pharmaceutical (019170 KS): Three Concerns Are Clouding the Upside Potential

Concerns regarding the slush fund is the major overhang on the stock price. Oral COVID-19 drug development cannot be considered a major catalyst...

Logo
374 Views
Share
bearishBNC Korea
29 Oct 2021 22:50

BNC Korea (256840 KS): Oral COVID-19 Treatment No More Remains a Catalyst

In-licensed oral COVID-19 treatment no longer remains a catalyst after competitor's encouraging clinical trial results. Other oral treatments are...

Logo
101 Views
Share
bearishLG Display
30 Sep 2021 19:22

Local Institutions Drive Higher Shorts in KOSPI

In this insight, we discuss the top 10 most heavily shorted stocks in KOSPI (amount shorted/market cap).These heavily shorted stocks have...

Logo
263 Views
Share
11 Sep 2021 05:48

Asia Shorts: Meituan, CMB, Li Ning, Sekisui, Toyo Seikan, Toshiba, Kakao, HMM, LGE, Wan Hai, TSMC

The Insight looks at movements in short interest across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
186 Views
Share
x